CTMX
CytomX Therapeutics, Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$5.67
$-0.40
(-6.59%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $960.70M | EPS (ttm) | $0.30 | Current Price | $5.67 |
| Enterprise Value | $822.67M | Forward EPS | $-0.37 | Previous Close | $6.07 |
| P/E Ratio | 18.90 | ROA | 9.78% | 52W High | $6.35 |
| Forward P/E | -15.42 | ROE | 66.76% | 52W Low | $0.40 |
| PEG Ratio | - | Gross Margin | 100.00% | 50 Day Avg | $4.50 |
| P/S Ratio | 8.45 | Operating Margin | -264.43% | 200 Day Avg | $2.96 |
| P/B Ratio | 8.71 | Profit Margin | 24.66% | Volume | 4.65M |
| EV/EBITDA | 33.54 | Current Ratio | 3.64 | Avg Volume | 3.15M |
| EV/Sales | 7.24 | Quick Ratio | 3.54 | Beta | 2.43 |
| Employees | 119.00 | Debt/Equity | 5.21 | Shares Outstanding | 169.44M |
| Sector | Healthcare | Total Debt | $5.60M | Float Shares | 131.77M |
| Industry | Biotechnology | Total Cash | $143.63M | Short Float | 9.86% |
| Optionable | Yes | Cash/Share | $0.85 | Short Ratio | 5.45 |
| Dividend Yield | - | Book Value/Share | $0.65 | % Held by Insiders | 0.57% |
| Target Price | $9.00 | Revenue (TTM) | $113.63M | % Held by Institutions | 88.50% |